23 May 2013
Keywords: president, ceo, emd, pharmaceuticals, named, matthew, emmens
Article | 30 September 1999
Matthew Emmens has been named to the posts of president and chiefexecutive of Merck KGaA of Germany's new US unit, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 September 1999
29 September 1999
23 September 1999
© 2013 thepharmaletter.com